Alemtuzumab reduced the risk of relapse by 55% in early-stage multiple sclerosis - http://bit.ly/ut4tdw
1:21 PM - 27 Oct 2011
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.